EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Six-Minute Walk Distance and Long-Term Outcomes in Contemporary Left Ventricular Assist Device Recipients: The ELEVATE Registry

William Herrik Nielsen iD, Finn Gustafsson iD, Steven Shaw iD, Jens Garbade iD, Michiel Morshuis iD, Daniel Zimpfer iD, Jacob Lavee iD, Laura Walker iD, Carlye Kraemer iD, Carlo Gazzola iD, Diyar Saeed iD, ELEVATE Registry Investigators

Interdisciplinary CardioVascular and Thoracic Surgery · 03.11.2026 · 41 (11)

DOI: 10.1093/icvts/ivag241 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, online erschienen am 11.09.2026. Verfasst von William Herrik Nielsen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark. Hauptthemen laut MEDLINE: Heart-Assist Devices, Heart Failure, Walk Test, Ventricular Function, Left. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to assess the prognostic value of six-minute walk distance (6MWD) in stable HeartMate 3 (HM3) recipients.

Methods

Data from patients with available 6MWD at 6 months post-implant were obtained from the prospective, multicentre ELEVATE registry. Overall survival and adverse event rates were analysed using Cox regression models adjusted for age and sex, with 6MWD as a continuous predictor, and stratified by median distance (350 m).

Results

Six-minute walk distance at 6 months was available in 194 HM3 recipients. Patients walking < median were older (57 vs 52 years, P = .002), had more comorbidities, and reported lower quality of life. Six-minute walk distance correlated positively with haemoglobin (r = 0.20, P = .006) and EuroQoL-5 Dimensions visual analogue scale (EQ-5D VAS) (r = 0.23, P = .004), and inversely with New York Heart Association (NYHA) class (r = –0.47, P < .0001). Kaplan-Meier analyses of patients walking < or ≥ 350 m showed no significant differences in survival (log-rank P = .379), right heart failure (HF) (P = .334), or rehospitalization (P = .243), while survival free from haemocompatibility-related adverse events differed significantly, although marginally (P = .049). Cox models confirmed that 6MWD had no independent prognostic value for mortality (HR 0.98, 95% CI, 0.96-1.01, P = .26) or secondary outcomes. However, patients with < median 6MWD experienced higher rates of major bleeding (Incidence rate ratio (IRR) 2.88, P < .001), major infection (IRR 2.14, P < .0001), and renal dysfunction (IRR 4.78, P = .033).

Conclusions

Shorter 6MWD 6 months after HM3 implantation was associated with a higher risk of some adverse events (AEs) but was not prognostic for mortality, HF recurrence, or rehospitalization risk. The prognostic value of 6MWD in HF patients without circulatory support cannot be extrapolated to patients treated with current left ventricular assist devices (LVADs). Clinical trial registration number ClinicalTrials.gov Identifier: NCT02497950.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesHeart FailureWalk TestVentricular Function, LeftExercise ToleranceHumansFemaleRegistriesMaleMiddle AgedProspective StudiesTime FactorsRisk FactorsTreatment OutcomeQuality of LifeRecovery of FunctionAdultAgedPredictive Value of Tests

Stichwörter der Autor:innen

6MWDLVADadverse eventsprognosissix-minute walk distance

Autor:innen und Institutionen

  • Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen 2200, Denmark.
  • Heart Failure Division, Abbott Cardiovascular, Abbott Park, IL 60064, United States.
  • The Transplant Centre, Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester M23 9LT, United Kingdom.
  • Department of Cardiothoracic Surgery, Klinikum Links der Weser, Bremen 28277, Germany.
  • Department of Cardiothoracic Surgery, Herz- und Diabeteszentrum NRW, Bad Oeynhausen 32545, Germany.

ORCID-Profile: William Herrik Nielsen, Finn Gustafsson, Steven Shaw, Jens Garbade, Michiel Morshuis, Daniel Zimpfer, Jacob Lavee, Laura Walker, Carlye Kraemer, Carlo Gazzola, Diyar Saeed

Förderung

  • Abbott

Zitieren

APA

Nielsen, W. H., Gustafsson, F., Shaw, S., Garbade, J., Morshuis, M., Zimpfer, D., Lavee, J., Walker, L., Kraemer, C., Gazzola, C., Saeed, D., & ELEVATE Registry Investigators (2026). Six-Minute Walk Distance and Long-Term Outcomes in Contemporary Left Ventricular Assist Device Recipients: The ELEVATE Registry. Interdisciplinary CardioVascular and Thoracic Surgery, 41(11). https://doi.org/10.1093/icvts/ivag241

Vancouver

Nielsen WH, Gustafsson F, Shaw S, Garbade J, Morshuis M, Zimpfer D, et al. Six-Minute Walk Distance and Long-Term Outcomes in Contemporary Left Ventricular Assist Device Recipients: The ELEVATE Registry. Interdisciplinary CardioVascular and Thoracic Surgery. 2026;41(11). doi:10.1093/icvts/ivag241

BibTeX
@article{Nielsen2026,
  author = {Nielsen, William Herrik and Gustafsson, Finn and Shaw, Steven and Garbade, Jens and Morshuis, Michiel and Zimpfer, Daniel and Lavee, Jacob and Walker, Laura and Kraemer, Carlye and Gazzola, Carlo and Saeed, Diyar and ELEVATE Registry Investigators, ELEVATE Registry Investigators},
  title = {Six-Minute Walk Distance and Long-Term Outcomes in Contemporary Left Ventricular Assist Device Recipients: The ELEVATE Registry},
  journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
  year = {2026},
  volume = {41},
  number = {11},
  doi = {10.1093/icvts/ivag241}
}
Kostenlos starten →